Pandion Therapeutics, Inc. 

MA

  SEC # 1807901

        

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

Relationships

        

No  Owner Relationships  (where the Issuers of the  Pandion Therapeutics, Inc.-owned  securities are...)

        

First  20  of  98  Issuer Relationships  (where the Owners of the  Pandion Therapeutics, Inc.  securities are...)

First		Latest Filing		Filing		Filer / Owner
7/28/20		2/11/22		SC 13G		NY	Orbimed Advisors LLC
2/16/21		5/17/21		SC 13G		MA	Ra Capital Management, L.P. [ formerly Ra Capital Management, LLC ]
8/3/20		4/8/21		SC 13D			GSK plc [ formerly Glaxosmithkline plc ]
3/4/21		4/2/21		SC 13D		NY	AI Pan LLC
		4/1/21		25-NSE		NY	Nasdaq Stock Market LLC [ formerly The Nasdaq Stock Market LLC ]
7/21/20		4/1/21		4		NY	Becker Daniel J.
		4/1/21		4		MA	Beloff Gregg
7/21/20		4/1/21		4		CA	Carlo Rizzuto
7/21/20		4/1/21		4		FL	Carroll Jill
7/21/20		4/1/21		4		MA	Crane Alan L
12/4/20		4/1/21		4		ID	Dorton Katina
7/21/20		4/1/21		4		MA	Frail Donald
7/21/20		4/1/21		4		MA	Freedman Edward D.
7/21/20		4/1/21		4		CA	Fuglesang Christopher
7/21/20		4/1/21		4		PA	Goyal Vikas
7/21/20		4/1/21		4		MA	Kakkar Rahul
7/21/20		4/1/21		4		VT	Larson Eric D
7/21/20		4/1/21		4		MA	Stagliano Nancy
7/21/20		4/1/21		4		MA	Sundy John
7/21/20		4/1/21		4		CA	Viney Joanne L.
→Please Sign In to List all of them.

List all Money Managers that own this Security Issuer:  CUSIP 698340

        

First  20  of  54  Insider & Control Relationships  (Directors & Officers, Owners, Parent / Subs., et al.)

First		Latest Filing		Relationship		Registrant
7/16/20		4/1/21		Director		NY	Becker Daniel J.
7/16/20		4/1/21		Officer [ see Filings ]		MA	Beloff Gregg
7/16/20		4/1/21		Director		CA	Carlo Rizzuto
7/16/20		4/1/21		10% Owner		FL	Carroll Jill
7/16/20		4/1/21		Director			"
7/16/20		4/1/21		10% Owner		MA	Crane Alan L
7/16/20		4/1/21		Director			"
12/4/20		4/1/21		Director		ID	Dorton Katina
7/16/20		4/1/21		Director		MA	Frail Donald
7/16/20		4/1/21		Officer:  Chief Operating Officer		MA	Freedman Edward D.
7/16/20		4/1/21		10% Owner		CA	Fuglesang Christopher
7/16/20		4/1/21		Director			"
7/16/20		4/1/21		Officer [ see Filings ]		PA	Goyal Vikas
7/16/20		4/1/21		Director		MA	Kakkar Rahul
7/16/20		4/1/21		Officer:  Chief Executive Officer			"
7/16/20		4/1/21		Officer:  Vice President, Finance		VT	Larson Eric D
7/16/20		4/1/21		Director		MA	Stagliano Nancy
7/16/20		4/1/21		Officer:  Chief Medical Officer		MA	Sundy John
7/16/20		4/1/21		Officer [ see Filings ]		CA	Viney Joanne L.
		3/4/21		10% Owner		NJ	Merck & Co., Inc.
→Please Sign In to List all of them.

        

No  Joint-Filer Relationships  (Co-Filer Registrants:  Partners, Affiliates, et al.)

        

No  Group-Member Relationships  (Co-Filer Non-Registrants:  Partners, Affiliates, et al.)

        

Filing Agent Relationships  (SEC Filing Agents, Attorneys, Printers, et al. — Affiliates:  Directors & Officers, et al.)

7  Filing Agents and/or Registrants have submitted Filings for  Pandion Therapeutics, Inc.:

Latest Filing				Filing Agentª, Registrant or SEC — SEC #			Filings
		Type
4/12/21		15-12B		NY	Donnelley Financial Solutions/FA — 1193125		31
4/6/21		EFFECT			No Filing Agent:  SEC-filed by SEC #5 — 9999999995		3
3/12/21		10-K		TX	ActiveDisclosure/FA — 1564590		3
7/16/20		SEC LETTER			No Filing Agent:  SEC-filed by SEC #7 — 9999999997		1
7/16/20		CERT		NY	Nasdaq Stock Market LLC [ formerly The Nasdaq Stock Market LLC ] — 1354457		1
5/22/20		DRS		NY	Donnelley Financial Solutions/FA — 950123		1
4/7/20		D			No Filing Agent:  Self-filed — 1807901		1
Total:							41
__________  ª  Proprietary to SEC Info℠:  The SEC does not publish the names of SEC Filing Agents.